Related Experiment Video
Updated: Aug 17, 2026

A Reverse Genetic Approach to Test Functional Redundancy During Embryogenesis
Published on: August 11, 2010
Haploinsufficiency of the cardiac transcription factor Nkx2-5 variably affects the expression of putative target
Patrick Y Jay1, Olga Rozhitskaya, Oleg Tarnavski
1Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA. jay_p@kids.wustl.edu
Abstract:
Heterozygous mutations of the cardiac transcription factor Nkx2-5 cause congenital heart disease. To elucidate the molecular pathways of transcription factor mutant phenotypes or diseases, direct targets are commonly sought in studies of homozygous null mutant animals and by heterologous promoter-reporter gene transactivation assays. The expression of putative target genes in a physiologic range of transcription factor concentration, however, is often not examined. Heterozygous Nkx2-5 knockout (Nkx2-5+/-) mice have no more than half-normal levels of Nkx2-5 protein. We therefore measured the mRNA expression of four putative targets of the cardiac transcription factor Nkx2-5 in wild-type and Nkx2-5+/- animals in a variety of developmental and pathologic states. Wild-type and Nkx2-5+/- embryonic hearts expressed similar levels of atrial natriuretic factor (ANF), brain natriuretic peptide (BNP), the RNA helicase Csm, and homeodomain only protein HOP. In the failing adult ventricle, ANF and BNP were up-regulated to the same extent in wild-type and Nkx2-5+/- myocardium. Csm and HOP were down-regulated in heart failure, and Nkx2-5+/- hearts expressed about half-normal levels in healthy and failing states. No consistent relationship existed between the expression of putative transcriptional targets and Nkx2-5 gene dosage in the physiologically relevant range. Any dependence of gene expression on Nkx2-5 gene dosage is affected by factors specific to the individual gene and the physiologic context.
Insights
Heterozygous Nkx2-5 mutations cause heart defects. Studies show Nkx2-5 gene dosage doesn't consistently affect target gene expression in developing or failing hearts.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Molecular Genetics
Background:
- Heterozygous mutations in the cardiac transcription factor Nkx2-5 are linked to congenital heart disease.
- Understanding Nkx2-5's molecular pathways requires identifying its direct gene targets.
- Physiological expression levels of transcription factors are crucial for studying target gene regulation.
Purpose of the Study:
- To investigate the relationship between Nkx2-5 gene dosage and the expression of its putative target genes.
- To examine target gene expression in heterozygous Nkx2-5 knockout mice (Nkx2-5+/-) under various physiological conditions.
Main Methods:
- Quantitative analysis of mRNA expression for atrial natriuretic factor (ANF), brain natriuretic peptide (BNP), Csm, and HOP.
- Comparison of gene expression in wild-type and Nkx2-5+/- mice during embryonic development and in experimentally induced heart failure.
- Assessment of gene expression across a physiological range of Nkx2-5 protein levels.
Main Results:
- ANF and BNP levels were similar in wild-type and Nkx2-5+/- embryonic hearts and similarly upregulated in failing adult ventricles.
- Csm and HOP mRNA levels were downregulated in heart failure, with Nkx2-5+/- hearts showing approximately half-normal levels in both healthy and failing states.
- No consistent correlation was observed between Nkx2-5 gene dosage and the expression levels of these four putative target genes across different physiological contexts.
Conclusions:
- The dependence of putative Nkx2-5 target gene expression on gene dosage is gene-specific and context-dependent.
- Physiological Nkx2-5 levels in heterozygous mutants do not predictably alter the expression of all its target genes.
- Further research is needed to understand the complex regulatory mechanisms governing Nkx2-5 target gene expression in cardiac development and disease.
Related Concept Videos
General Transcription Factors
Transcription Factors
Master Transcription Regulators
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Pleiotropy
Cell Specific Gene Expression

